Korean J Obstet Gynecol.  2005 Jan;48(1):240-246.

A Case of Persistent Metastatic Gestational Trophoblastic Disease after Partial Hydatidiform Mole

Affiliations
  • 1Department of Obstetrics and Gynecology, University of Soonchunhyang, College of Medicine, Soonchunhyang University Chunan Hospital, Chunan, Korea. jinnie0927@hanmail.net
  • 2Department of Pathology, University of Soonchunhyang, College of Medicine, Soonchunhyang University Chunan Hospital, Chunan, Korea.

Abstract

Persistent tumor, usually non-metastatic, develops in approximately 4% of patients with a partial mole, and chemotherapy is required to achieve remission. Following evacuation of hydatidiform mole, careful hCG monitoring is mandatory since it is the most reliable and sensitive method for the early detection of gestational trophoblastic disease. In carefully selected patients in whom the risk of developing gestational trophoblastic disease is significant or when the availability of hCG testing is suboptimal, chemoprophylaxis has been shown to decrease the risk of gestational trophoblastic tumor. We report here a case of patient, 23- year-old woman who experienced unusual course after the evacuation of a partial mole and markedly elevated serum beta-hCG levels. The patient developed persistent metastatic gestational trophoblastic disease and was successfully treated with 3 courses of EMA-CO.

Keyword

Partial hydatidiform mole; Persistent metastatic gestational trophoblastic disease; Chemotherapy

MeSH Terms

Chemoprevention
Drug Therapy
Female
Gestational Trophoblastic Disease*
Humans
Hydatidiform Mole*
Pregnancy
Trophoblastic Neoplasms
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr